Rabies antibody seroprotection rates among travelers in Nepal: "Rabies seroprotection in travelers"

Journal of Travel Medicine

Volumn 13, Issue 6, 2006, Pages 329-333

  Ranney, Megan ^a   Partridge, Robert ^a   Jay, Gregory D ^a   Eastman Rozzoli, Deborah ^a   Pandey, Prativa ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b CIWEC Travel Medicine Centre Nepal   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

DIPLOID CELL VACCINE; PURIFIED VERO CELL RABIES VACCINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVENIENCE SAMPLE; DATA ANALYSIS; DEMOGRAPHY; DILUTION; EMPORIATRICS; FEMALE; FLUORESCENCE; HEALTH CENTER; HUMAN; IMMUNIZATION; MALE; MEASUREMENT; NEPAL; RABIES; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEPAL; PROSPECTIVE STUDIES; RABIES; RABIES VACCINES; RABIES VIRUS; TRAVEL;

EID: 33750874325     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00067.x     Document Type: Article

References (20)

1. Noah DL, Drenzek CL, Smith JS, et al. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998; 128:922-930.
2. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004; 363:959-969.
3. Centers for Disease Control and Prevention. Human Rabies - Florida, 2004. MMWR Morb Mortal Wkly Rep 2005; 54:767-769.
4. Centers for Disease Control and Prevention. Human Rabies - New Hampshire 1996. MMWR Morb Mortal Wkly Rep 1997; 46:267-270.
5. Mitmoonpitak C, Wilde H, Tepsumetanon W. Current status of animal rabies in Thailand. J Vet Med Sci 1997; 59:457-460.
6. Centers for Disease Control and Prevention. Human Rabies Prevention - United States, 1999: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 1999; 48:1-21.
7. LeGuerrier P, Pilon PA, Deshaies D, et al. Pre-exposure prophylaxis for the international traveler: a decision analysis. Vaccine 1996; 14:167-176.
8. Nicholson KG, Turner GS, Aoki FY. Immunization with a human diploid cell strain of rabies vaccine: two-year results. J Infect Dis 1978; 137:783-788.
9. Pandey P, Shlim DR, Cave W, et al. Risk of possible exposure to rabies among tourists and foreign residents in Nepal. J Travel Med 2002; 9:127-131.
10. Wilde H, Briggs DJ, Meslin FX, et al. Rabies update for travel medicine advisors. Clin Infect Dis 2003; 37:96-100.
11. Moran GJ, Taln DA, Mower W, et al. Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. JAMA 2000; 284:1001-1007
12. Hoey J, Todkill A. Fatal case of rabies. Can Med Assoc J 1997; 156:1311-1312. (Editorial)
13. Strady C, Jaussaud R, Beguinot I, et al. Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy. Vaccine 2000; 18:2661-2667.
14. Strady A, Lang J, Lienard M, et al. Antibody persistence following pre-exposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 1998; 177:1290-1295.
15. Gherardin AW, Scrimgeour DJ, Lau SC, et al. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine. J Travel Med 2001; 8:122-126.
16. Jaijaroensup W, Limusanmo S, Khawplod P, et al. Immunogenicity of rabies postexposure booster injections in subjects who had previously received intradermal preexposure vaccination. J Travel Med 1999; 6:234-237.
17. Briggs DJ, Schwenke JR. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 1992; 10:125-129.
18. Fishbein DB, Dressen DW, Holmes F, et al. Human diploid cell rabies vaccine purified by zonal centrifugation: a controlled study of antibody response and side effects following primary and booster pre-exposure immunizations. Vaccine 1989; 7:437-442.
19. Lau C, Sisson J. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 2002; 9:285-288.
20. Leder K, Weller PF, Wilson ME. Travel vaccines and elderly persons: review of vaccines available in the United States. Clin Infect Dis 2001; 33:1553-1566.